Andrea Piasentin

54 posts

Andrea Piasentin banner
Andrea Piasentin

Andrea Piasentin

@Piase6

MD, Young resident in Urology at @UrologiaTrieste

Joined Mayıs 2020
194 Following80 Followers
Andrea Piasentin retweeted
Dr. Chacón-Lozsán F .'.
Dr. Chacón-Lozsán F .'.@franciscojlk·
🩻Contrast-induced AKI: one of the biggest myths still shaping clinical decisions For decades we were taught: 👉 “Contrast damages the kidneys” 👉 “Avoid CT with contrast in CKD” 👉 “Hydrate, protect, delay imaging if needed” But what if… most of this is wrong?🤔 ->The uncomfortable reality Modern evidence shows: 👉 Low-osmolar contrast rarely causes true nephrotoxicity 👉 Even in CKD, AKI, and ICU patients 👉 The risk is often overestimated—or nonexistent So where did the fear come from? 📍 1950s high-osmolar contrast (actually toxic) 📍 Poorly controlled observational studies 📍 “Creatinine rise = contrast injury” assumption 👉 Correlation became causation 👉 And the dogma stayed ⚠️What recent data tells us ✔ No difference in AKI rates with vs without contrast ✔ No benefit from bicarbonate, NAC, or aggressive hydration ✔ Even ICU and AKI patients show no worsening outcomes ->Translation to real life 👉 The patient was going to develop AKI anyway...Not because of contrast!! ->The real problem: “Renalism” 👉 Avoiding necessary imaging 👉 Delaying diagnosis 👉 Choosing inferior tests And that leads to: ❌ Missed PE ❌ Delayed sepsis source control ❌ Worse outcomes ->Clinical mindset shift Instead of asking: 👉 “Will contrast harm the kidneys?” We should ask: 👉 “Will NOT doing the scan harm the patient?” ->Who still deserves caution? ✔ eGFR <30 ✔ Severe hemodynamic instability ✔ Multiple nephrotoxins Even then: 👉 Optimize volume 👉 Minimize dose 👉 Don’t delay critical imaging 🤓Bottom line ✔ Contrast nephrotoxicity exists… but is rare ✔ The fear is bigger than the risk ✔ The harm of NOT imaging is often greater In critical care 👉 We don’t treat creatinine 👉 We treat patients And sometimes… 👉 The most dangerous thing is NOT the contrast 👉 It’s hesitation. 📃Reference Florens N, Demiselle J. Kidney360 7: 445–449, 2026. doi: doi.org/10.34067/KID.0…
Dr. Chacón-Lozsán F .'. tweet media
English
20
405
984
216.4K
Andrea Piasentin retweeted
Dr Rishabh Jain
Dr Rishabh Jain@DrRishabhOnco·
💥 “Screen or not to screen?” After 23 years, ERSPC finally answers. 📊 ERSPC (n = 162,236 men, 55–69 yrs) 🔹 Screening: repeated PSA testing 🔹 Control: no screening ⏱️ Median follow-up: 23 yrs 🎯 Results 🧬 ↓ Prostate cancer mortality: 1.4% vs 1.6% (RR 0.87 [0.80–0.95]) ➡️ 13% relative & 0.22% absolute risk reduction 📈 NNI = 456 | NND = 12 → better harm–benefit ratio ⚠️ Overdiagnosis: +27 extra cases / 1000 men (mostly low-risk) 🧩 Who should be screened? ✅ Men 50–69 y with ≥15 y life expectancy ✅ Earlier (40–45 y) if BRCA2+, family history, or African ancestry 🚫 Stop if >70 y, frail, or PSA < 1 ng/mL at 60 y 💡 Takeaway: PSA screening saves lives - just not everyone’s. Target the right men, at the right age, using risk-based + MRI-guided screening. 📖 Roobol MJ et al. NEJM 2025 🔗doi.org/10.1056/NEJMoa… #OncoTwitter #MedTwitter #ProstateCancer #Screening #ESMO25 @OncoAlert @myesmo @esmo_open @ASCO @NEJM @Uroweb @AmerUrological @UrologyTimes @EUplatinum
Dr Rishabh Jain tweet media
English
13
85
206
28.9K
Andrea Piasentin retweeted
Università di Trieste
Università di Trieste@UniTrieste·
🔵 Bollino Azzurro "Onda" alla Clinica universitaria di Urologia La Clinica urologica dell’Ospedale di Cattinara, sede della Scuola di Specializzazione in Urologia di UniTS, si conferma un’eccellenza nazionale nel trattamento del tumore della prostata 🔎 u.garr.it/M5ywo
Università di Trieste tweet media
Italiano
1
4
18
634
Andrea Piasentin retweeted
Università di Trieste
Università di Trieste@UniTrieste·
Premio per la Scuola di Specializzazione UniTS in Urologia al congresso della Società Italiana di Andrologia. Leggi qui ► u.garr.it/8oFQG
Università di Trieste tweet media
Italiano
0
3
11
643
Andrea Piasentin retweeted
Cameron Alexander
Cameron Alexander@CamEAlexander·
If we forgo basic functional assessment of the testes and expedite orchidectomy, how do we know which patients may have benefited from other fertility preservation options (e.g. onco-microTESE) until it’s potentially too late?
Cameron Alexander tweet media
English
1
4
5
1K
Andrea Piasentin
Andrea Piasentin@Piase6·
Happy to share the results of our study, supporting the use of 12-core systematic PB along with MRI-target biopsies. Thanks @FraClaps and all the co-authors. @GiulioRossin @fanfa92 @ongarluc_1991 @MicheleRizzo85 @Trombetta_Carl @gioliguori33
Dept. of Urology | University of Trieste@UrologiaTrieste

Dr. @Piase6’s insights on the 1st day of #EAU24 in #Paris: diagnostic accuracy of mpMRI, target and systematic prostate biopsy for the detection of cribriform #prostatecancer @Uroweb @UniTrieste @AsugiFVG

English
0
2
5
533